BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced
today that on August 8, 2014, it received a letter from the NASDAQ OMX
GROUP (“Nasdaq”) stating that the bid price of the Company’s common
stock for the last 30 consecutive trading days had closed below the
minimum $1.00 per share required for continued listing under Listing
The Nasdaq notification letter does not result in the immediate
delisting of the Company’s common stock, and the stock will continue to
trade uninterrupted on the The Nasdaq Capital Market under the symbol
BSD management intends to resolve the situation to allow for continued
listing on The Nasdaq Capital Market.
DANYANG, China , June 23, 2014 /PRNewswire/ -- On June 17, 2014 , Lihua International, Inc. (the "Company"), received a letter from The NASDAQ Stock Market LLC ("Nasdaq"), which stated that the Nasdaq Staff has determined to delist the Company's securities pursuant to its discretionary authority under Listing Rule 5101.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.